{"disease":{"id":"pre-emptive-pharmacogenomics","name":"pre emptive pharmacogenomics"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05504135","title":"Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)","phase":"","overall_status":"COMPLETED","enrollment_count":222,"lead_sponsor_name":"Nalagenetics Pte Ltd","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}